Press release from Companies: All patients have completed AcuCort's phase IV study ZEQ001

Press release from Companies: Samtliga patienter har genomgått AcuCorts Fas IV-studie ZEQ001

Press release from Companies: AcuCort reschedules publication date for third quarter interim report

Press release from Companies: AcuCort senarelägger datum för publicering av delårsrapport för tredje kvartalet

Press release from Companies: AcuCort appoints nomination committee

Press release from Companies: Valberedning i AcuCort utsedd

Press release from Companies: AcuCort granted extended SME status by the European Medicines Agency (EMA)

Press release from Companies: AcuCort beviljas förlängd SME-status av den europeiska läkemedelsmyndigheten (EMA)

Press release from Companies: Zeqmelit® Launched in Norway and Finland

Press release from Companies: Zeqmelit® har lanserats i Norge och Finland

Press release from Companies: AcuCort Presents Study Results at the ISPOR Scientific Conference in Barcelona

Press release from Companies: AcuCort presenterar studieresultat på den vetenskapliga konferensen ISPOR i Barcelona